Patent ID: 8540955

Claim:
A method for producing an aluminum phosphate vaccine adjuvant comprising: mixing a solution of aluminum chloride and a solution of sodium phosphate tribasic to produce an aluminum phosphate suspension and a supernatant, wherein the solution of sodium phosphate tribasic is added to the solution of aluminum chloride until the pH is in the range of 5.0 to 5.4; settling the aluminum phosphate suspension to produce an aluminum phosphate precipitate, wherein the settling step is performed for a period of about 2 days to about 5 days and at a temperature of about 60° C.; removing the supernatant, wherein the steps of mixing, settling and removing are performed within a closed system; sterilizing the aluminum phosphate precipitate, wherein the step of sterilizing comprises heating the aluminum phosphate precipitate to a temperature in excess of 110° C.; and adjusting the pH of the aluminum phosphate precipitate to be in the range of 5.6 to 6.0, wherein after the step of adjusting the pH, the aluminum phosphate precipitate includes particles with a size distribution having a D [v, 0.5] in the range of 3.0 μm to 9.0 μm.